{"name":"Theralase® Technologies Inc.","slug":"theralase-technologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOWWhtUVJZU2phQ014Y0g1TnFJd0VnME5kTXpiX0I5QjRlU01TbG9IUGdvMDNnX3FEMXZMRlNiSW1Mb3RDVWJmVVNZWjh2WC0yTWpJSExiTnU1NGhQT25TWlpvZ1VhWmIxSTdXRUFoRVBKRDgwM2llXzhHUWpSeEpZVlR2LUs1T0FIaC1zRDc2Nks3TXoxNGtrTXdKSVV2QQ?oc=5","date":"2026-03-10","type":"pipeline","source":"TMX Newsfile","summary":"Theralase(R) Closes $1.1 M Non-Brokered Private Placement - TMX Newsfile","headline":"Theralase(R) Closes $1.1 M Non-Brokered Private Placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOVXE3SnBxRkpGYWRCLXJHa2tRZHJCY252M0V0OVhwS2NYNHBPQklmZjRPYndnSklnOS05QWxjUHNTRk5lOWxPNlhLMW0ybE4tZHpBWThMbTNpN3pNZjFmOG16OF9KdFp2SnNMQ0F1Snd1Q3FuV3JOcUpSaVlBMnpBWmVNTGgtZnIzTlhxNzNQRDVGWHc0VVJkXzJUUElUM29qYXczVDc5cHVzWXduR0dpeXhQSXlGeFd5VG9hTVpycnpDQnp6MWptYnFMU0k0Z2ozaEN3WEtyV3lMM0ZIdEg0bTVWRUtTUQ?oc=5","date":"2026-02-17","type":"trial","source":"TMX Newsfile","summary":"Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress - TMX Newsfile","headline":"Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQZW1hQXctVVMwclZIdF9QWC1GX3hxOUFGVXpZbE5rQUQ1NkNHekgxTUZVWFo3UEtLdkJGRUZXeXNlcXEzNVJLWWVUX0FXSjVyTzl3UEdHaEhQbVhJc0s5d3F1RTA5TWNqRTdZZHVSNi1EOEFnM2h3b0toUnJFRFZCd2tZYUp2YXhKcWVuM3VUaVAzRHJ2MXhBYlUzX1RDMVpMNEdZTldxdGlEeFZz?oc=5","date":"2026-02-02","type":"trial","source":"TMX Newsfile","summary":"Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study - TMX Newsfile","headline":"Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQMkhfQnNJMlVMQ1pJMnFJQUNMbFVrQzFBSkNVMnc2d1J1ZFJyN2o5X2tteU5QX0RRRk9jbE10U0N5TjhQelhlMUtVQmJiZDdDdE9Ya1ZYcWk2bW1xcGx6dEpySUo4LXVlcW5zQXVDeC03eWtBeS1QY0tqNmNsaTJUQlBoSXM3Y2NvX19wdkNVamNPRVlCYndqZUFYajhhZF9kWVJV?oc=5","date":"2026-01-12","type":"pipeline","source":"Yahoo Finance","summary":"Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Yahoo Finance","headline":"Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQLUVZR1B5T0ItbjBMZmRkenBOX0Nic1Q1R1c1NENZU0t1U3BXU3JBR2xrWGtIZkdqaEFWMnFqdUJibmMwN05TNFZ0dTB2MjY2c1Q3dVhYUjUzOEM1UkFCVFN1NWRra3ZTYWs5Y0tvNHBlejZjRHprNmF5SUZGZEdRRlBlbnpIYllxMTJ3ZGZ3UmFnOGE2UlpMMXBMYW00bFlCNy1XdDlKWEJNQUpDS3k1ZXJjQkdDenlVVFptOExONmZMMUZTNG9adnZwclVOQTBwd0FnbVUyRkJBOUJfNmNoZQ?oc=5","date":"2026-01-12","type":"deal","source":"roi-nj.com","summary":"Ferring Pharmaceuticals partners with Theralase to investigate combination therapy for bladder cancer - roi-nj.com","headline":"Ferring Pharmaceuticals partners with Theralase to investigate combination therapy for bladder cancer - roi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPY05kYnVKdElPVUtMRVBLSjFPam4yZndaRkxUWl81OWdhV3liS0c4clpMRnBRaUhGNC1WdGhYM253c3I3alh0aWlHb2R6SlRJX3BkTkxkY1dleXhuQmNrVm0tTDlBZXV4WUFpem9Wc3pONzNqcnpqUEdsT1ZyVGFtam04NWpXOWNnQnhGUGZINmFoWms4MnhrS1JKb1lZRmpTaE9wVENSTTd5d0dtYnlyNHdiNVpuaUlFQm52TGpn?oc=5","date":"2026-01-12","type":"trial","source":"Stockhouse","summary":"Theralase and Ferring ink deal for new bladder cancer study | 2026-01-12 | Investing News - Stockhouse","headline":"Theralase and Ferring ink deal for new bladder cancer study | 2026-01-12 | Investing News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5kTldVODd2cXk1TkFqMEE5VE5ZYkloX21mSmlEZkphbjExN1pZSzR3WFotUk5HVEwtVS0tZ21tN0wtMUNZWktWUHRlby1XUGF2OC1EZDR6WUM3UlMzaWJVQ1Z5Y0hmU2pPaUdhdndxaU1lLWFKbW5ySnlTVQ?oc=5","date":"2026-01-12","type":"deal","source":"Stockhouse","summary":"TSXV:TLT Forum Post | Oden6570-36854819 | Theralase and Ferring ink deal | Theralase Technologies Inc - Stockhouse","headline":"TSXV:TLT Forum Post | Oden6570-36854819 | Theralase and Ferring ink deal | Theralase Technologies Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBHYl9fQnI1NldjT2dOUW9HVVlmanl2ckEyN3p6S21OYnlwZXJhNTR5S1RXb2F5bFpCc0RZUUxIdk5GUUJDdnN2WjRyVW95U3I4cXFSUw?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"TLTFF Stock Price, News & Analysis - Stock Titan","headline":"TLTFF Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNNFBTeWppckdJSWNpT0I3Slg2YTF6a1RoTngzS3BwQ3Fpb2QwQTV5U19aaThVcTJJQnRybjktblVfSG1qZ2xVSnZkUzBSRXJFZTVGVUd6cWI2TjlUU01ydy1GR0VmRkwwQ3BseXViWkFmV1hvbk9XSEJYYkZuTVRHSE5HR2l3dEJGSFpnUlNwWFloLVdLYXFKOFRUcGM3djNvcnZmQzNSVGVHTHZnQ1ZodXd2YjNGRHpqM3ZSUGxnUUdEclRVMGR4UVVnS1l0S1dEeHNUUnEtdkx2Y1BIenFVNjZJQzFwR3pvV1E?oc=5","date":"2024-06-19","type":"pipeline","source":"Proactive Investors","summary":"Theralese Technologies reports complete response in preclinical lung cancer model - Proactive Investors","headline":"Theralese Technologies reports complete response in preclinical lung cancer model","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}